These results indicate that hLMR1 and mLMR1 may play a similar role in inducing steatosis, with dysregulated hLMR1 in patients with NAFLD potentially being pathogenic. The gene discussed is HLMR1; the disease is metabolic dysfunction-associated steatotic liver disease.